TABLE 2.
Summary of adverse events of the involved studies.
| Study | Group | Number | Number of adverse reactions | Adverse reactions |
|---|---|---|---|---|
| Zou et al. (2018) | Trial | 43 | NR | Mild flushed face, dry mouth, dizziness |
| Control | 43 | NR | NR | |
| Zhang et al. (2021) | Trial | 42 | 2 | Nausea, vomiting |
| Control | 42 | 6 | Flushed face, dry mouth, nausea, vomiting | |
| Li et al. (2021) | Trial | 60 | 13 | Elevated alanine aminotransferase, dizziness, fatigue, gastrointestinal reactions |
| Control | 60 | 6 | Elevated alanine aminotransferase, fatigue, gastrointestinal reactions | |
| Dong et al. (2021) | Trial | 100 | 12 | Flushed face, dry mouth |
| Control | 101 | 8 | Nausea, vomiting | |
| Zhang (2022) | Trial | 21 | NR | No adverse reactions occurred |
| Control | 21 | NR | No adverse reactions occurred | |
| Jiang et al. (2022) | Trial | 193 | NR | Mild flushed face, dry mouth, bitter mouth, loss of appetite |
| Control | 193 | NR | Mild flushed face, dry mouth, bitter mouth, loss of appetite | |
| Zhang et al. (2022) | Trial | 16 | NR | No adverse reactions occurred |
| Control | 16 | NR | No adverse reactions occurred |
Note: NR, not reported.